These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6235744

  • 1. Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma.
    Mannucci PM, Gringeri A, Ammassari M, Mari D.
    Am J Hematol; 1984 Aug; 17(2):167-76. PubMed ID: 6235744
    [Abstract] [Full Text] [Related]

  • 2. [Hemophilia and HTLV-III infection].
    Lechler E.
    Z Hautkr; 1986 Dec 01; 61(23):1687-704. PubMed ID: 2949442
    [Abstract] [Full Text] [Related]

  • 3. Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV, Lewis JH, Spero JA, Bontempo FA, Rabin BS.
    Am J Med; 1984 Feb 01; 76(2):206-10. PubMed ID: 6230009
    [Abstract] [Full Text] [Related]

  • 4. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H.
    Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759
    [Abstract] [Full Text] [Related]

  • 5. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R, Veitch SE, Edmond E, Peutherer JF, Prescott RJ, Steel CM, Ludlam CA.
    Lancet; 1984 Jun 30; 1(8392):1431-4. PubMed ID: 6145879
    [Abstract] [Full Text] [Related]

  • 6. Abnormal T-cell subpopulations in hemophilic patients receiving factor VIII concentrates from voluntary donors.
    Wearne A, Joshua DE, Rickard KA, Kronenberg H.
    Aust N Z J Med; 1984 Apr 30; 14(2):149-53. PubMed ID: 6236788
    [Abstract] [Full Text] [Related]

  • 7. Decreased helper-suppressor cell ratios following treatment with blood products: factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV, Lewis JH, Spero JA, Bontempo FA, Rabin BS.
    Scand J Haematol Suppl; 1984 Apr 30; 40():371. PubMed ID: 6236552
    [No Abstract] [Full Text] [Related]

  • 8. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G, Böttiger B, Karlsson A, Sandström E, Morfeldt-Månsson L, Blombäck M, Nilsson IM, Wiechel B, Saxinger C, Gallo R.
    Cancer Res; 1985 Sep 30; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [Abstract] [Full Text] [Related]

  • 9. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K.
    Thromb Haemost; 1983 Aug 30; 50(2):552-6. PubMed ID: 6314582
    [Abstract] [Full Text] [Related]

  • 10. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate.
    Unzeitig JC, Church JA, Gomperts ED, Nye CA, Pasquale S, Richards W.
    Am J Dis Child; 1984 Jul 30; 138(7):645-8. PubMed ID: 6233901
    [Abstract] [Full Text] [Related]

  • 11. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
    Aznar JA, Carbonell F, Jorquera JI, Carmona E, Sánchez-Cuenca JM, Trénor A, de Andrés-Medina R, González-Molina A.
    Ric Clin Lab; 1985 Jul 30; 15(4):315-21. PubMed ID: 3938863
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P, Mariani G, Mannucci PM, De Rossi G, Nicoletti L, Titti F, Falcione E, Pasqualetti D, Ammassari M, Gringeri A.
    J Med Virol; 1986 Jun 30; 19(2):143-9. PubMed ID: 3014059
    [Abstract] [Full Text] [Related]

  • 13. A study of cell mediated and humoral immunity in haemophilia and related disorders.
    Moffat EH, Bloom AL, Jones J, Matthews N, Newcombe RG.
    Br J Haematol; 1985 Sep 30; 61(1):157-67. PubMed ID: 3931666
    [Abstract] [Full Text] [Related]

  • 14. Studies of cellular immunity in male homosexuals in London.
    Pinching AJ, McManus TJ, Jeffries DJ, Moshtael O, Donaghy M, Parkin JM, Munday PE, Harris JR.
    Lancet; 1983 Jul 16; 2(8342):126-30. PubMed ID: 6134980
    [Abstract] [Full Text] [Related]

  • 15. Effects of exposure to factor concentrates containing donations from identified AIDS patients. A matched cohort study.
    Jason J, Holman RC, Dixon G, Lawrence DN, Bozeman LH, Chorba TL, Tregillus L, Evatt BL.
    JAMA; 1986 Oct 03; 256(13):1758-62. PubMed ID: 3018305
    [Abstract] [Full Text] [Related]

  • 16. Altered distribution of T-lymphocyte subpopulations in children and adolescents with haemophilia.
    Luban NL, Kelleher JF, Reaman GH.
    Lancet; 1983 Mar 05; 1(8323):503-5. PubMed ID: 6131213
    [Abstract] [Full Text] [Related]

  • 17. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

  • 18. Controlled prospective study of factor IX concentrate therapy and immunodeficiency.
    Hultin MB, Dattwyler RJ, Lipton RA.
    Am J Hematol; 1989 May 21; 31(1):71-2. PubMed ID: 2523189
    [Abstract] [Full Text] [Related]

  • 19. AIDS and immunologic abnormalities in European and American hemophiliacs.
    Green D.
    Scand J Haematol Suppl; 1984 May 21; 40():367-9. PubMed ID: 6433463
    [No Abstract] [Full Text] [Related]

  • 20. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS, Madhok R, Forbes CD, Lennie SE, Lowe GD, Sturrock RD.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1091-3. PubMed ID: 6226334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.